FDA Logo--links to FDA home page
U.S. Food and Drug Administration
HHS Log--links to Department of Health and Human Services website
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program


 
 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- March 2009

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format

Summary View

 

 

Brand (Generic) Name

Sections Modified

Summary of Changes to Contraindications and Warnings

Epzicom (abacavir sulfate and lamivudine)
Tablets

Prescribing Information and Medication Guide

 

BOXED WARNING

CONTRAINDICATIONS

WARNINGS

PRECAUTIONS

  • Myocardial Infarction
    • In a published...the use of abacavir within the previous 6 months was correlated with an increased risk of myocardial infarction (MI)...

MEDICATION GUIDE

  • revised to include information related to myocardial infarction

BOXED WARNING

  • Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitvity reaction to abacavir. Prior to initiating therapy .....
  • Regardless of HLA-B*5701 status permanently discontinue Epzicom if hypersensitivity cannot be ruled out...
  • Following a hypersensitivity reaction to abacavir, NEVER restart Epzicom... severe symptoms can occur within hours .....
  • Reintroduction of Epzicom or any other abacavir-containing product...can result in serious or fatal .....

CONTRAINDICATIONS

  • Never restart Epzicom or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status....

WARNINGS

  • ...Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir...

clear pixel

clear pixel

clear pixel

OsmoPrep (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets

Prescribing Information and Medication Guide

See MedWatch Safety Alert posted 12/11/2008 for additional information on OsmoPrep labeling revisions.

BOXED WARNING

  • New

ADVERSE REACTIONS

  • Postmarketing Experience
    • General
      • Added (tongue) ..swelling of the lips and tongue..
    • Cardiovascular: Arrhythmias
    • Nervous system: Seizures
    • Renal
      • acute phosphate nephropathy added

MEDICATION GUIDE

  • New

BOXED WARNING

  • There have been rare, but serious reports of acute phosphate nephropathy in patients who received oral sodium phosphate products for colon cleansing prior to colonoscopy. Some cases have resulted in permanent impairment of renal function and some patients required long-term dialysis. While some cases have occurred in patients without identifiable risk factors, patients at increased risk of acute phosphate nephropathy may include ....

clear pixel

clear pixel

clear pixel

Raptiva (efalizumab)

Prescribing Information and Medication Guide

See MedWatch Safety Alert posted 01/19/2009 for additional information on Raptiva labeling revisions.

BOXED WARNING

CONTRAINDICATIONS

WARNINGS

  • Progressive Multifocal Leukoencephalopathy (PML)

PRECAUTIONS

  • Information for Patients
    • Healthcare providers should counsel patients about the risks and benefits of Raptiva...

ADVERSE REACTIONS

  • The most serious adverse reactions observed during treatment with Raptiva are serious infections, including PML...
  • In postmarketing experience, serious bacterial, viral, fungal, and opportunistic infections
    have occurred, including JC virus infection resulting in PML...

MEDICATION GUIDE

  • Conversion of the Patient Package Insert to a Medication Guide

BOXED WARNING

  • Warning: Risk of Progressive Mutifocal Leukoencephalopathy (PML)
    • Raptiva increases the risk for PML, a rapidly progressive viral infection of the central nervous system that...
    • Patients on Raptiva should be monitored frequently...
    • Raptiva dosing should be withheld immediately at the first sign or symptom suggestive of PML...

CONTRAINDICATIONS

  • should not be administered to patients who have been diagnosed with PML

WARNINGS

  • Progressive Multifocal Leukoencephalopathy (PML)
    • PML is a rapidly progressive infection of the central nervous system caused by the JC virus that leads to death or severe disability.
    • Raptiva increases the risk for PML and this risk may markedly increase with longer duration ..... Post-marketing cases...
    • The effect of intermittent use of Raptiva...
    • Healthcare providers treating patients with Raptiva should consider...

clear pixel

clear pixel

clear pixel

Sporanox (itraconazole) Oral Solution, 10 mg/mL

Prescribing Information

BOXED WARNING

  • Drug Interactions

CONTRAINDICATIONS

  • Congestive Heart Failure
  • Drug Interactions

WARNINGS

  • Cardiac Dysrhythmias
  • Cardiac Disease
  • Treatment of Severely Neutropenic Patients

PRECAUTIONS

  • Hearing Loss
    • Transient or permanent hearing loss has been reported .....
  • Information for Patients
    • Instruct patients that hearing loss can occur...
  • Drug Interactions Table additions
    • ...disopyramide..(including nisoldipine)..levacetylmethadol (levomethadyl), ergot alkaloids, halofantrine..budesonide,
      dexamethasone, fluticasone..warfarin, cilostazol, eletriptan, fentanyl...
  • Antiarrhythmics
    • The class IA antiarrhythmic disopyramide has the potential to increase the QT interval...
    • ...via inhibition of P glycoprotein.
  • Calcium Channel Blockers
    • ...due to an increased risk of CHF. Concomitant administration of Sporanox and nisoldipine results in...
  • Other
    • Levacetylmethadol (levomethadyl) is known to prolong the QT...
    • Elevated concentrations of ergot alkaloids can cause ergotism...
    • Halofantrine has the potential to prolong the QT interval...
    • Sporanox may..."glucocorticosteroids such as budesonide, dexamethasone, fluticasone and"...
    • Cilostazol and eletriptan are CYP3A4 metabolized...
    • Fentanyl plasma concentrations could...
  • Pregnancy:Teratogenic Effects, Pregnancy Category C
    • During post-marketing experience, cases of congenital abnormalities have been reported.
  • Geriatric Use (new section)
  • Renal Impairment (new section)
  • Hepatic Impairment (new section)

ADVERSE REACTIONS

  • Postmarketing Experience
    • Revised and table updated
      • Transient or permanent hearing loss

BOXED WARNING

  • Drug Interactions
    • Coadministration of "levacetylmethadol (levomethadyl)" addition
    • ..sudden death have occurred in patients using "levacetylmethadol (levomethadyl)"...

CONTRAINDICATIONS

  • Congestive Heart Failure (new section)
  • Drug Interactions
    • nisoldipine
    • levacetylmethadol
      (levomethadyl)
    • Ergot alkaloids metabolized...

WARNINGS

  • Cardiac Dysrhythmias
    • levacetylmethadol (levomethadyl)
  • Cardiac Disease
    • Itraconazole has been shown to have a negative inotropic effect.
    • Sporanox has been associated with reports of congestive heart failure. In post-marketing...
    • Calcium channel blockers can have negative inotropic effects
  • Treatment of Severely Neutropenic Patients (new section)

clear pixel

clear pixel

clear pixel

Trizivir (abacavir sulfate, lamivudine, and zidovudine) Tablets

Prescribing Information

BOXED WARNING

CONTRAINDICATIONS

WARNINGS

  • Hypersensitivity Reaction

PRECAUTIONS

  • Myocardial Infarction

MEDICATION GUIDE

  • Observed During Clinical Practice
    • Cardiovascular: Myocardial infarction.

BOXED WARNING

  • Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitvity reaction to abacavir...

CONTRAINDICATIONS

  • Trizivir tablets are contraindicated in patients with previously demonstrated hypersensitivity to abacavir or to any other component of the product...
  • Never restart Trizivir or any other abacavir-containing product...

WARNINGS

  • Hypersensitivity Reaction
    • Serious and sometimes fatal hypersensitivity reactions have
      been associated with Trizivir...
    • HLA-B*5701-negative patients may develop a hypersensitivity reaction to abacavir...

clear pixel

clear pixel

clear pixel

Visicol Tablets
(sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP)

Prescribing Information and Medication Guide

See MedWatch Safety Alert posted 12/11/2008 for additional information on Visicol labeling revisions.

BOXED WARNING

  • New

ADVERSE REACTIONS

  • Postmarketing Experience
    • Rewritten to match OsmoPrep format

MEDICATION GUIDE

  • New Medication Guide

BOXED WARNING

    There have been rare, but serious reports of acute phosphate nephropathy in patients who received oral sodium phosphate products for colon cleansing prior to colonoscopy. Some cases have resulted in permanent impairment of renal function and some patients required long-term dialysis. While some cases have occurred in patients without identifiable risk factors, patients at increased risk of acute phosphate nephropathy may include ...

Back to Summary Page | Back to Top

Brand (Generic) Name

Sections Modified

Summary of Changes to Contraindications and Warnings

Diabeta (glyburide) Tablets

Prescribing Information

CONTRAINDICATIONS

PRECAUTIONS

  • Hemolytic anemia
  • There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction
  • Drug Interactions
    • Clarithromycin (hypoglycemic action of sulfonylureas may be potentiated)
    • bosentan and cyclosporine

CONTRAINDICATIONS

  • hypersensitivity to any of the drug’s excipients and patients treated with bosentan

clear pixel

clear pixel

clear pixel

Macrobid (nitrofurantoin monohydrate/macrocrystals) Capsules, 100 mg

Prescribing Information

CONTRAINDICATIONS

WARNINGS

CONTRAINDICATIONS

  • Macrodantin is contraindicated in patients with a previous history of cholestatic jaundice/hepatic dysfunction associated with nitrofurantoin.

WARNINGS

  • Added subheadings for readability of the following reactions:
    • Pulmonary reactions
    • Hepatoxicity
    • Neuropathy
    • Hemolytic anemia
    • Clostridium difficile-associated diarrhea

clear pixel

clear pixel

clear pixel

Macrodantin (nitrofurantoin monohydrate/macrocrystals) Capsules, 25, 50 and 100 mg

Prescribing Information

CONTRAINDICATIONS

WARNINGS

CONTRAINDICATIONS

  • Macrodantin is contraindicated in patients with a previous history of cholestatic jaundice/hepatic dysfunction associated with nitrofurantoin.

WARNINGS

  • Added subheadings for readability of the following reactions:
    • Pulmonary reactions
    • Hepatoxicity
    • Neuropathy
    • Hemolytic anemia
    • Clostridium difficile-associated diarrhea

clear pixel

clear pixel

clear pixel

Rocephin (ceftriaxone sodium) for injection, 250 mg, 500 mg, 1 g and 2 g

Prescribing Information

CONTRAINDICATIONS

  • Neonates

WARNINGS

  • Interaction with Calcium-Containing Products

ADVERSE REACTIONS

  • Postmarketing Experience
    • A small number of cases of fatal outcomes in which a crystalline material was observed in the lungs and kidneys at autopsy have been reported...

CONTRAINDICATIONS

  • Neonates (section edited)
    • Rocephin is contraindicated in neonates if they require...
    • A small number of cases of fatal outcomes in which a crystalline material was observed in the lungs and kidneys at autopsy...

WARNINGS

  • Interaction with Calcium-Containing Products
    • Do not use diluents containing calcium, such as Ringer’s solution or Hartmann’s solution, to reconstitute Rocephin vials...

clear pixel

clear pixel

clear pixel

Sporanox (itraconazole) Capsules, 100 mg

Prescribing Information and Patient Package Insert

CONTRAINDICATIONS

  • Drug Interactions

WARNINGS

  • Cardiac Disease

PRECAUTIONS

  • Hearing Loss
    • Transient or permanent hearing loss has been reported .....
  • Information for Patients
    • Instruct patients that hearing loss can occur...
  • Antiarrhythmics
    • Concomitant administration of digoxin...added "via inhibition of P-glycoprotein"
  • Drug Interactions/Calcium Channel Blockers
    • added...due to an increased risk of CHF. Concomitant administration of Sporanox and nisoldipine results in...
  • Drug Interactions/Other
    • fluticasone
    • Fentanyl plasma concentrations could be increased or prolonged by concomitant use of Sporanox and may cause potentially fatal respiratory depression
  • Geriatric Use
    • Transient or permanent hearing loss has been reported...
  • Renal Impairment (new)
  • Hepatic Impairment (new)

ADVERSE REACTIONS

  • Post-marketing Experience (replaced with table)
    • Adverse drug reactions that have been identified during post-approval use of Sporanox (all formulations) are listed ...

PATIENT PACKAGE INSERT

  • Who Should Not Take Sporanox and What Are The Possible Side Effects Of Sporanox section

CONTRAINDICATIONS

  • Drug Interactions
    • nisoldipine

WARNINGS

  • Cardiac Disease
    • Sporanox has been associated with reports of congestive heart failure. In post-marketing...
    • Calcium channel blockers can have negative inotropic effects

clear pixel

clear pixel

clear pixel

Sporanox (itraconazole) Injection, 10 mg/mL

Prescribing Information

CONTRAINDICATIONS

  • Drug Interactions

WARNINGS

  • Cardiac Disease

PRECAUTIONS

  • Hearing Loss
    • Transient or permanent hearing loss has been reported ...
  • Information for Patients
    • Instruct patients that hearing loss can occur...
  • Antiarrhythmics
    • Concomitant administration of digoxin...added "via inhibition of P-glycoprotein"
  • Drug Interactions/Calcium Channel Blockers
    • added...due to an increased risk of CHF. Concomitant administration of Sporanox and nisoldipine results in...
  • Drug Interactions/Other
    • fluticasone
    • Fentanyl plasma concentrations could be increased or prolonged by concomitant use of Sporanox and may cause potentially fatal respiratory depression
  • Geriatric Use
    • Transient or permanent hearing loss has been reported...
  • Renal Impairment (new)
  • Hepatic Impairment (new)

ADVERSE REACTIONS

  • Post-marketing Experience (replaced with table)
    • Adverse drug reactions that have been identified during post-approval use of Sporanox (all formulations) are listed...

PATIENT PACKAGE INSERT

  • Who Should Not Take Sporanox and What Are The Possible Side Effects Of Sporanox section

CONTRAINDICATIONS

  • Drug Interactions
    • nisoldipine
    • Sporanox IV cannot be used when administration of Sodium Chloride Injection is
      contraindicated.

WARNINGS

  • Cardiac Disease
    • Itraconazole has been shown to have a negative inotropic effect.
    • Sporanox has been associated with reports of congestive heart failure. In post-marketing...
    • Calcium channel blockers can have negative inotropic effects

clear pixel

clear pixel

clear pixel

Theophylline in 5% Dextrose injection, USP, Flexible Plastic Container

Prescribing Information

CONTRAINDICATIONS

WARNINGS

  • When Signs and Symptoms of Theophylline Toxicity are Present

PRECAUTIONS

  • Monitoring Serum Theophylline Concentrations
    • "Saliva concentrations of theophylline cannot be used reliably to adjust dosage without special techniques...
    • Clinical evaluation and periodic laboratory determinations are necessary to monitor changes...
    • ..Do not use plastic container in series connection...
    • ..These solutions are intended for intravenous administration...
    • ..Use only if solution is clear and container and seals are intact.

ADVERSE REACTIONS

  • Hypercalcemia has been reported in a patient with hyperthyroid disease at therapeutic theophylline concentrations.
  • “Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.

CONTRAINDICATIONS

  • Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products

WARNINGS

  • When Signs and Symptoms of Theophylline Toxicity are Present
    • “Solutions containing dextrose without electrolytes should not be administered simultaneously with blood through the same infusion set... ...Because dosages of these drugs are titrated to response, no additives should be made to Theophylline in 5% Dextrose Injection USP."

clear pixel

clear pixel

clear pixel

Tracleer (bosentan) 62.5 and 125 mg Tablets

Prescribing Information and Medication Guide

CONTRAINDICATIONS

  • Lopinavir/ritonavir or other ritonavir-containing HIV regimens

PRECAUTIONS

  • Drug Interactions (section reworded)
    • Bosentan is metabolized by CYP2C9 and CYP3A4. Inhibition of these enzymes may increase the plasma concentration of bosentan...
  • Lopinavir/ritonavir or other ritonavir-containing HIV regimens
    • Co-administration of Tracleer in healthy subjects resulted in initial and steady...

MEDICATION GUIDE

  • Do not take Tracleer if...
    • lopinavir/ritonavir or other ritonavir-containing HIV regimens
  • Tell your doctor about all the medicines you use..
    • lopinavir/ritonavir or other ritonavir-containing HIV regimens
  • What should I avoid..
    • Do not take cyclosporine-A...increase your chance of side effects
    • Do not take lopinavir/ritonavir or other ritonavir-containing HIV regimens

CONTRAINDICATIONS

  • Lopinavir/ritonavir or other ritonavir-containing HIV regimens
    • Co-administration of lopinavir/ritonavir and bosentan resulted in markedly increased plasma concentrations of bosentan.Therefore, concomitant use of Tracleer and lopinavir/ritonavir or other ritonavir-containing HIV regimens is contraindicated...

Back to Summary Page | Back to Top

Brand (Generic) Name

Sections Modified

Summary of Changes to Contraindications and Warnings

Advair Diskus (fluticasone propionate and salmeterol xinafoate inhalation powder)

The latest label (3/31/2009) is not available on this site

WARNINGS AND PRECAUTIONS

  • Reduction in Bone Mineral Density

WARNINGS and PRECAUTIONS

  • Reduction in Bone Mineral Density
    • 2-Year Fluticasone Propionate Study
    • 3-Year Bone Mineral Density Study
    • 3-Year Survival Study

clear pixel

clear pixel

clear pixel

Altace (ramipril) 1.25, 2.5, 5, and 10 Capsules

Altace (ramipril) 1.25, 2.5, 5 and 10 mg Tablets

The latest label (approved 03/04/2009) is not available on this site

WARNINGS

  • Fetal/Neonatal Morbidity and Mortality

PRECAUTIONS

  • Information for Patients/Pregnancy
    • Female patients of childbearing age should be told about the consequences of exposure to ACE inhibitors during pregnancy. These patients should be asked to report pregnancies to their physicians as soon as possible.

WARNINGS

  • Fetal/Neonatal Morbidity and Mortality
    • In a published retrospective epidemiological study, infants whose mothers had taken an ACE inhibitor during their first trimester of pregnancy appeared to have an increased risk of major congenital malformations...findings of this study have not yet been confirmed.

clear pixel

clear pixel

clear pixel

Axert (almotriptan malate) Tablets 6.25 and 12.5 mg

Prescribing Information

WARNINGS

  • Serotonin Syndrome

PRECAUTIONS

  • Drug Interactions
    • Selective Serotonin Reuptake Inhibitors/Serotonin Norephinephrine Reuptake Inhibitors and Serotonin Syndrome
  • Information for Patients
    • separate leaflet provided for patients
    • Patients should be cautioned about the risk of serotonin syndrome...

ADVERSE REACTIONS

  • Postmarketing Experience
    • Includes reports of seizure in close temporal association with triptan use

PATIENT PACKAGE INSERT

  • Includes information concerning serotonin syndrome with concomitant use of triptans and SSRIs/SNRIs

WARNINGS

  • Serotonin Syndrome

clear pixel

clear pixel

clear pixel

Cymbalta (duloxetine hydrochloride) Delayed- Release Capsules 20, 30 and 60 mg

Prescribing Information

WARNINGS AND PRECAUTIONS

  • Discontinuation of Treatment with Cymbalta

ADVERSE REACTIONS

  • Other Adverse Reactions observed during the premarketing and postmarketing clinical trial evaluation of Duloxetine
    • Ear and Labyrinth Disorders
      • ... and tinnitus
    • General Disorders and Administration Site Conditions
      • ... gait disturbance
    • Nervous System Disorders
      • ...and poor quality sleep
    • Renal and Urinary Disorders
      • polyuria
    • Reproductive System and Breast Disorders
      • ...and sexual dysfunction
    • Skin and Subcutaneous Tissue Disorders
      • dermatitis contact
  • Postmarketing Spontaneous Reports
    • aggression and anger (particularly early in treatment or after treatment discontinuation)
    • gynecological bleeding
    • muscle spasm
    • restless legs syndrome, seizures upon treatment
      discontinuation
    • tinnitus (upon treatment discontinuation)

MEDICATION GUIDE

  • Toll free number

WARNINGS and PRECAUTIONS

  • Discontinuation of Treatment with Cymbalta
    • words "tapered" and "fatigue" inserted in the section

 

clear pixel

clear pixel

clear pixel

Frova (frovatriptan succinate) Tablets 2.5 mg

Prescribing Information

WARNINGS AND PRECAUTIONS

ADVERSE REACTIONS

  • Postmarketing Experience
    • reports of seizure in close temporal association with triptan use

PATIENT PACKAGE INSERT

  • information concerning serotonin syndrome with concomitant use of triptans and SSRIs/SNRIs

WARNINGS AND PRECAUTIONS

  • Includes information concerning serotonin syndrome with concomitant use of triptans and SSRIs/SNRIs

clear pixel

clear pixel

clear pixel

Lexiscan (regadenoson) Injection

Prescribing Information

 

WARNINGS AND PRECAUTIONS

ADVERSE REACTIONS

  • (6.1) Clinical Trials Experience
  • (6.2) Post Marketing Experience
    • Cardiovascular
    • Gastrointestinal
    • Musculoskeletal
    • Respiratory

WARNINGS AND PRECAUTIONS

  • Sinoatrial and Atrioventricular Nodal Block
    • In postmarketing experience, third degree heart block and asystole within minutes of Lexiscan administration have occurred
  • Hypotension
    • In postmarketing experience, syncope and transient ischemic attacks have been observed

clear pixel

clear pixel

clear pixel

Spiriva HandiHaler inhalation powder

Prescribing Information and New Patient Package Insert

WARNINGS

ADVERSE REACTIONS

  • added "(new onset or worsening)" to glaucoma

PATIENT PACKAGE INSERT

  • New

WARNINGS

  • section updated symptoms of angioedema: (including swelling of the lips, tongue or throat), itching, and rash

Back to Summary Page | Back to Top

Brand (Generic) Name
Sections Modified

NegGram (nalidixic acid) Caplets

Prescribing Information

PRECAUTIONS

  • General subsection text modified
    • Caution should be used in patients with renal insufficiency (term "severe" & "failure" removed) and subsequent sentence removed

clear pixel

clear pixel

Novothyrox (levothyroxine sodium) Tablets

Prescribing Information

PRECAUTIONS

  • agents such as iron and calcium supplements and antacids can decrease the absorption of levothyroxine tablets
  • instructions for reporting side effects to FDA
  • drug-drug interaction between levothyroxine and orlistat

clear pixel

clear pixel
Tarka (trandolopril/verapamil hydrochloride) 2/180, 1/240, 2/240, 4/240 mg ER Tablets 

The latest label (approved 3/5/2009) is not available on this site

 

PRECAUTIONS

  • Drug Interactions (the following interactions have been added):
    • Clarithromycin
      • Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients receiving concurrent clarithromycin.
    • Erythromycin
      • Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients
        receiving concurrent erythromycin ethylsuccinate.
    • Gold
      • Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including Tarka.

clear pixel

clear pixel

Zithromax (azithromcyin) for Oral Suspension, 200 mg, 500 mg, Single Dose Packet, 600 mg, IV

Prescribing Information

PRECAUTIONS

  • General
    • Exacerbation of symptoms of myasthenia gravis and new onset of myasthenic syndrome have been reported in patients receiving azithromycin therapy.
  • Precautions -Drug Interactions
    • Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.

Back to Summary Page | Back to Top

Brand (Generic) Name
Sections Modified

Clinoril (sulindac) Tablets

Prescribing Information

ADVERSE REACTIONS

  • Hypersensitivity Reactions

clear pixel

clear pixel

Cosmegen (dactinomycin) for Injection

Prescribing Information

ADVERSE REACTIONS

  • Hematologic Section
    • addition of neutropenia and febrile neutropenia

clear pixel

clear pixel
Crestor (rosuvastatin calcium) Tablets 

Prescribing Information

ADVERSE REACTIONS

  • Postmarketing Experience
    • hepatic failure

clear pixel

clear pixel

Demerol (meperidine hydrochloride) Tablets and Oral Solution

Prescribing Information

ADVERSE REACTIONS

  • Hypersensitivity reactions including anaphylaxis

clear pixel

clear pixel

Eloxatin (oxaliplatin) powder for solution for intravenous use

Eloxatin (oxaliplatin) concentrate for solution for intravenous use

Prescribing Information

ADVERSE REACTIONS

  • Postmarketing Experience
    • after other interstitial lung diseases added "sometimes fatal"
    • transient vision loss (reversible following therapy discontinuation)

Information for Patients

  • Updated ... vision abnormalities that may affect patients’ ability to drive and
    use machines.

clear pixel

clear pixel

Lipitor (atorvastatin calcium) Tablets

Prescribing Information

ADVERSE REACTIONS

  • Postintroduction Reports
    • hepatic failure

clear pixel

clear pixel

Niaspan (niacin extended release) tablet

The latest label (approved 03/26/2009) is not available on this site

ADVERSE REACTIONS

  • Post-marketing adverse event
    • blurred vision, hepatitis, myopathy, creatine kinase increase, and skin discoloration

clear pixel

clear pixel

Vancocin Hcl (vancomycin for injection, USP) 500 mg/100mL and 1g/200mL

Prescribing Information

ADVERSE REACTIONS

  • Post Marketing Reports
    • Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)

Back to Summary Page | Back to Top

Brand (Generic) Name
Sections Modified

Dalmane (flurazepam hydrochloride), 15 mg and 30 mg oral Capsules

Prescribing Information

MEDICATION GUIDE

  • New Medication Guide

clear pixel

clear pixel
Prozac (fluoxetine hydrochloride) capsules 

Prescribing Information and Medication Guide

MEDICATION GUIDE

clear pixel

clear pixel

Symbyax (olanzapine/fluoxetine) capsules

Prescribing Information and Medication Guide

MEDICATION GUIDE

  • New Medication Guide

clear pixel

clear pixel

Synagis (palivizumab)

Patient Package Insert

PATIENT PACKAGE INSERT

  • New PPI

clear pixel

clear pixel

Zyprexa (olanzapine) Tablet

Zyprexa Zydis (olanzapine) Tablet, Orally Disintegrating

Prescribing Information and Medication Guide

MEDICATION GUIDE

  • New Medication Guide

Back to Summary Page | Back to Top